6565 Results

People

  1. Gonen
    Gonen
  2. Panageas
    Panageas
  3. Patil
    Patil
  4. Giralt
    Giralt
  5. Zhang
    Zhang
  6. Heller
    Heller
  7. Devlin
    Devlin
  8. Seshan
    Seshan
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)
  7. Population Sciences Research Program (2339)
  8. Center for Pancreatic Cancer Research (2080)
  9. GSK Faculty (1978)
  10. Department of Pathology and Laboratory Medicine (1573)
  1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors (PF) in advanced hepatocellular carcinoma (AHCC): Multivariate analysis and comparison between staging systems (SS) in patients (pts) treated at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Huitzil, F. D.; Capanu, M.; Jacobs, G.; Smith, W.; O'Reilly, E.; Shah, M.; Schwartz, G. K.; Saltz, L. B.; Kelsen, D. P.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Evaluation of number of target lesions to analyze in time to progression by RECIST
    Meeting Abstract

    Gonen, M.; Schwartz, L.; Ford, R.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Feldman, D. R.; Kondagunta, G. V.; Ronnen, E. A.; Fischer, P.; Chang, R.; Baum, M.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Meeting Abstract

    Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?
    Meeting Abstract

    Ekenel, M.; Iwamoto, F. M.; Ben Porat, L. S.; Panageas, K. S.; Yahalom, J.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)
    Meeting Abstract

    Duffy, A.; Capanu, M.; Abou-Alfa, G. K.; Huitzel, D.; Williams, P.; Jarnagin, W.; Fong, Y.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis)
    Meeting Abstract

    Carvajal, R. D.; Tse, A.; Wu, N.; Gonen, M.; Lefkowitz, R.; Dials, H.; Barbi, A.; Mui, J.; Schwartz, G. K.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term toxicity monitoring via electronic patient reported outcomes in end-stage chemotherapy patients
    Meeting Abstract

    Basch, E. M.; Iasonos, A.; Barz, A.; Culkin, A.; Kris, M. G.; Artz, D.; Fearn, P.; Speakman, J.; Scher, H. I.; Schrag, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A nomogram predicting survival of patients (pts) with metastatic or unresectable urothelial cancer (UC) treated with cisplatin-based chemotherapy
    Meeting Abstract

    Bajorin, D. F.; Ostrovnaya, I.; Iasonos, A.; Milowsky, M. I.; Boyle, M.; Riches, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save